ADVERTISEMENT
Posted: Jan 17, 2024

Pharmacy organizations raise concerns about Florida’s drug importation program

WASHINGTON - Our pharmacy organizations are deeply concerned about FDA’s recent authorization of a state drug importation program, which could open the door for harmful and counterfeit drugs to enter our nation’s drug supply, with no evidence that this will result in cost savings for our patients.

Read more
Posted: Jan 10, 2024

APhA Announces Nahata as the 2024 Remington Honor Medal Recipient

WASHINGTON - Today, the American Pharmacists Association (APhA) began announcing the selection of the 2024 APhA Awards and Honors Program recipients. The APhA Awards and Honors Program is the most comprehensive recognition program in the profession of pharmacy.

Read more
Posted: Jan 8, 2024

APhA announces candidates for president-elect, trustees, and honorary president

WASHINGTON, DC—The American Pharmacists Association (APhA) announced the slate of candidates for its board of trustees, president-elect, and honorary president today. The elections for these positions will be held March 22, 2024, through May 6, 2024

Read more
Posted: Jan 5, 2024

FDA’s decision on Florida’s importation program jeopardizes patient safety

WASHINGTON, DC — The American Pharmacists Association (APhA) is dismayed that FDA gave the green light to Florida to import prescription drugs from Canada, jeopardizing patient safety and compromising our nations’ drug supply.

Read more
Posted: Jan 4, 2024

Mark Pilkington is the new executive director of Pharmacy Profiles, LLC

WASHINGTON, DC — Today the American Pharmacists Association (APhA) is pleased to announce Mark Pilkington, BPharm, MS, as the executive director of Pharmacy Profiles, LLC.

Read more
First678911131415Last

Related Articles

Advertisement
Advertisement
Advertisement
Advertisement
ADVERTISEMENT